J. Berger

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension.

X. Prieur, C. Le May, J. Hadchouel, 2014, Atherosclerosis.

Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1

B. Pillot, X. Prieur, C. Le May, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of PCSK9 does not improve lipopolysaccharide-induced mortality in mice[S]

J. Gromada, J. Horton, Norma N. Anderson, 2017, Journal of Lipid Research.

Transintestinal cholesterol excretion in health and disease

C. Le May, B. Cariou, D. Garçon, 2022, Current Atherosclerosis Reports.

Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content

Y. Moon, J. Berger, 2021, Molecules and cells.